Rosacea is one of the most undertreated skin conditions in Canada, with many sufferers dismissing persistent facial redness and pimples as "sensitive skin" or "adult acne" for years before receiving a diagnosis. Toronto's dermatologists are increasingly educating patients about Soolantra (Ivermectin 1% cream) as the most evidence-supported topical treatment for papulopustular rosacea, now accessible at affordable cost through Unnati Pharmax.
Toronto's diverse, multicultural population experiences rosacea across all skin tones — though it can be harder to diagnose in darker skin types where the classic redness is less visible. Soolantra's anti-Demodex and anti-inflammatory mechanisms work regardless of skin tone, making it appropriate for Toronto's full demographic diversity.
Indian-manufactured Ivermectin 1% cream provides identical clinical performance to brand Soolantra. Visit medshopy.com or WhatsApp +91 82650 41513.
Toronto's diverse, multicultural population experiences rosacea across all skin tones — though it can be harder to diagnose in darker skin types where the classic redness is less visible. Soolantra's anti-Demodex and anti-inflammatory mechanisms work regardless of skin tone, making it appropriate for Toronto's full demographic diversity.
Indian-manufactured Ivermectin 1% cream provides identical clinical performance to brand Soolantra. Visit medshopy.com or WhatsApp +91 82650 41513.
Can Soolantra help with the redness (erythema) of rosacea, or only the pimples?Soolantra (Ivermectin 1%) primarily targets the inflammatory papules and pustules of papulopustular rosacea — this is where its clinical trial evidence and treatment indication are strongest. It has some secondary anti-inflammatory activity that may modestly reduce background redness over time, but it is not primarily indicated for treating erythematotelangiectatic rosacea (the type characterised predominantly by persistent redness and visible blood vessels, without papules). For patients whose main concern is persistent facial redness, laser therapy and topical Brimonidine gel (a vascular constrictor) are more targeted treatment options. Many rosacea patients have overlapping subtypes and benefit from combination approaches targeting both concerns.